Kavar Capital Partners Group’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$205K Hold
14,250
0.03% 207
2025
Q4
$214K Buy
+14,250
New +$214K 0.03% 177
2025
Q2
Sell
-19,500
Closed -$291K 194
2025
Q1
$291K Sell
19,500
-750
-4% -$11.7K 0.05% 142
2024
Q4
$292K Sell
20,250
-10,500
-34% -$163K 0.05% 140
2024
Q3
$487K Hold
30,750
0.08% 122
2024
Q2
$472K Sell
30,750
-2,750
-8% -$41.7K 0.09% 110
2024
Q1
$549K Sell
33,500
-34,750
-51% -$548K 0.1% 107
2023
Q4
$1,000K Buy
68,250
+15,817
+30% +$221K 0.11% 101
2023
Q3
$756K Sell
52,433
-2,727
-5% -$42.5K 0.16% 92
2023
Q2
$906K Sell
55,160
-4,727
-8% -$77K 0.19% 88
2023
Q1
$1M Sell
59,887
-2,353
-4% -$37.9K 0.22% 85
2022
Q4
$960K Sell
62,240
-6,298
-9% -$97.5K 0.22% 83
2022
Q3
$1.02M Sell
68,538
-980
-1% -$16.2K 0.26% 81
2022
Q2
$1.14M Buy
69,518
+518
+0.8% +$8.88K 0.26% 79
2022
Q1
$1.38M Buy
69,000
+29,250
+74% +$607K 0.3% 80
2021
Q4
$1.01M Hold
39,750
0.21% 91
2021
Q3
$1.07M Hold
39,750
0.24% 89
2021
Q2
$1.15M Hold
39,750
0.28% 87
2021
Q1
$1.04M Sell
39,750
-2,750
-6% -$78K 0.28% 82
2020
Q4
$1.22M Hold
42,500
0.35% 70
2020
Q3
$1.01M Buy
+42,500
New +$980K 0.34% 71

Other funds holding BMEZ

Kavar Capital Partners Group's BMEZ Position: Q1 2026 in Review

Kavar Capital Partners Group held its BlackRock Health Sciences Trust II (BMEZ) position steady in Q1 2026 at 14,250 shares worth $205K. The position accounts for 0.03% of the portfolio, ranked #207.

Kavar Capital Partners Group first reported a position in BMEZ in Q3 2020 and has held it in 21 quarters since. The position peaked at $1.38M in Q1 2022. 88 funds tracked by Wall St. Rank hold BMEZ as of Q1 2026.

  • Kavar Capital Partners Group held 14,250 shares of BlackRock Health Sciences Trust II worth $205K as of Q1 2026.
  • Kavar Capital Partners Group left its BlackRock Health Sciences Trust II share count unchanged in Q1 2026.
  • BlackRock Health Sciences Trust II made up 0.03% of Kavar Capital Partners Group's portfolio in Q1 2026, its #207 holding.
  • Kavar Capital Partners Group first reported a position in BlackRock Health Sciences Trust II in Q3 2020 and has held it in 21 quarters since.
  • Kavar Capital Partners Group's BlackRock Health Sciences Trust II position peaked at $1.38M in Q1 2022.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2026.

Based on Kavar Capital Partners Group's 13F filing for Q1 2026, filed 16 Apr 2026.